South San Francisco, CA September 4, 2020 Submitted by Genentech Genentech Announces FDA Approval of Gavreto (pralsetinib) for the Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer Gavreto is a once-daily, oral precision therapy that selectively inhibits…